The combination of peptide nucleic acid mediated RT-PCR clamping has been shown to be sensitive enough to detect FGFR3 mutations in bladder cancer from urine sediments, clearly distinguishing mutant DNA from wild-type DNA at concentrations greater than 1% [82]. The gene discussed is FGFR3; the disease is urinary bladder carcinoma.